Diploma PLC (LON:DPLM – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 5,726.17 and traded as high as GBX 6,765. Diploma shares last traded at GBX 6,685, with a volume of 383,568 shares changing hands.
Analysts Set New Price Targets
Several research firms recently issued reports on DPLM. Berenberg Bank boosted their price target on Diploma from GBX 6,600 to GBX 7,500 and gave the company a “buy” rating in a research note on Thursday, March 19th. JPMorgan Chase & Co. boosted their price target on Diploma from GBX 5,120 to GBX 5,760 and gave the company a “neutral” rating in a research note on Friday, March 27th. Royal Bank Of Canada boosted their price target on Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a research note on Thursday, March 19th. Jefferies Financial Group boosted their price target on Diploma from GBX 5,200 to GBX 5,700 and gave the company a “hold” rating in a research note on Monday, March 23rd. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research note on Thursday, March 19th. Five research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,251.25.
Check Out Our Latest Research Report on Diploma
Diploma Price Performance
Insiders Place Their Bets
In related news, insider Ian El-Mokadem acquired 500 shares of the company’s stock in a transaction on Friday, March 20th. The stock was purchased at an average cost of GBX 5,820 per share, with a total value of £29,100. 1.14% of the stock is owned by corporate insiders.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
